Evaluation of Body-worn Multimodal Hand Hygiene System. Impact on Health-Care Associated Infections

Completed

• Conditions: Nosocomial Infection
• Interventions: Device: Body worn alcohol gel dispenser; Drug: 62% ethanol based hand cleanser; Behavioral: Educational component with regard to teaching CDC guidelines; Behavioral: Provider and group feedback

• Registration Number: NCT01050608
• Lead Sponsor: Dartmouth-Hitchcock Medical Center

Brief Summary

Evaluate the efficacy of a multimodal hand hygiene system in the intensive care unit environment and evaluate any impact on health care associated infections.

Detailed Description

Deploy and utilize a novel body worn hand hygiene system that incorporates provider and group specific feedback allowing hand hygiene to occur directly within the patient environment. We hypothesize that by improving provider hand hygiene we will reduce health-care associated infection rates.

Study Timeline

• Study Start: 2007-12
• Primary Completion: 2009-12
• Study First Submitted: 2010-01-14
• Study First Submitted QC: 2010-01-14
• Study First Posted: 2010-01-15
• Study Completion: 2011-01
• Status Verified: 2011-06
• Last Update Submitted: 2011-06-22
• Last Update Posted: 2011-06-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2954

Inclusion Criteria

• All ICU patients

Exclusion Criteria

• Patient is not in an ICU at our Institution

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Sprixx Device Group	Body worn alcohol gel dispenser	Treatment group utilizing multimodal hand hygiene device
Sprixx Device Group	62% ethanol based hand cleanser	Treatment group utilizing multimodal hand hygiene device
Sprixx Device Group	Educational component with regard to teaching CDC guidelines	Treatment group utilizing multimodal hand hygiene device
Sprixx Device Group	Provider and group feedback	Treatment group utilizing multimodal hand hygiene device

Primary Outcome Measures

Name	Time	Method
Reduction in healthcare associated infections (CRBSI and VAP)	2 years

Secondary Outcome Measures

Name	Time	Method
Time to infections Hospital mortality Length of stay	2 years

Trial Locations

Locations (1)

Dartmouth-HItchcock Medical Center; 🇺🇸 Lebanon, New Hampshire, United States